🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
The purpose of this study is to see whether combination treatment of Teclis...
Status
Recruiting
Location
University of Miami
Start Date
2023-12-04
Trial ID
NCT06100237
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Status
Active Not Recruiting
Location
Transplant-nephrology department
Start Date
2025-11-01
Trial ID
NCT07274462
Treatments Being Tested
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested
The purpose of this study is to evaluate the tolerability and safety of sub...
Status
Completed
Location
National Hospital Organization Shibukawa Medical Center
Start Date
2017-08-10
Trial ID
NCT03242889
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested